Literature DB >> 2987005

DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T1/2) cells.

J V Tricoli, B M Sahai, P J McCormick, S J Jarlinski, J S Bertram, D Kowalski.   

Abstract

We have used C3H 10T1/2 cells to examine the regulation of topoisomerase activities during cell proliferation and the cell cycle. The specific activity of topoisomerase I was about 4-fold greater in proliferating (log phase) cells than in non-proliferating (confluent) cells. In synchronized cells, the bulk of the increased activity occurred during or just prior to S phase, depending upon the method of synchronization. A smaller increase in activity also occurred during G1 phase. The increase in activity during S phase was not altered by a hydroxyurea block at the G1/S phase boundary indicating that it is not directly coupled to DNA synthesis and is not the result of topoisomerase I gene dosage. The increase was inhibited by blocking cells at mid-G1 phase using isoleucine deprivation. Thus, the increase in activity during S phase is dependent on events occurring during mid- to late G1 phase. In contrast to the changes in topoisomerase I levels, the specific activity of topoisomerase II showed no detectable difference in proliferating vs non-proliferating cells. In addition, no detectable difference in topoisomerase II specific activity was seen in G1, S and M phases of the cell cycle. The differences in the activity profiles of the topoisomerases I and II during the cell cycle suggest that the two activities are regulated independently and may be required for different functions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987005     DOI: 10.1016/0014-4827(85)90426-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.

Authors:  S V Gollapudi; B Vayuvegula; S Gupta; M Fok; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

2.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Authors:  Refael Peleg; Marianna Romzova; Inga Kogan-Zviagin; Ron N Apte; Esther Priel
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

4.  Gene expression of human DNA polymerase alpha during cell proliferation and the cell cycle.

Authors:  A F Wahl; A M Geis; B H Spain; S W Wong; D Korn; T S Wang
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

5.  Structural and evolutionary implications of the packaging of DNA for differentiation and proliferation in the lymphocyte.

Authors:  J G Kaplan; D L Brown; N Chaly; W L Greer; K V Prasad; A Severini; B M Sahai
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

6.  Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features.

Authors:  G Tuccari; A Rizzo; G Giuffrè; G Barresi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.

Authors:  D A Burden; L J Goldsmith; D M Sullivan
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

8.  Influence of topoisomerase II on the formation of oxygen-dependent radiation-induced DNA damage.

Authors:  H Zhang; K T Wheeler
Journal:  Br J Cancer Suppl       Date:  1996-07

9.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

Authors:  T Andoh; K Ishii; Y Suzuki; Y Ikegami; Y Kusunoki; Y Takemoto; K Okada
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  DNA-Binding and Topoisomerase-I-Suppressing Activities of Novel Vanadium Compound Van-7.

Authors:  Xiao-Mei Mo; Zhan-Fang Chen; Xin Qi; Yan-Tuan Li; Jing Li
Journal:  Bioinorg Chem Appl       Date:  2012-09-30       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.